Convergence of genes and cellular pathways dysregulated in autism spectrum disorders
Dalila Pinto,Elsa Delaby,Daniele Merico,Mafalda Barbosa,Alison Merikangas,Lambertus Klei,Bhooma Thiruvahindrapuram,Xiao Xu,Robert Ziman,Zhuozhi Wang,Jacob A S Vorstman,Ann Thompson,Regina Regan,Marion Pilorge,Giovanna Pellecchia,Alistair T Pagnamenta,Bárbara Oliveira,Christian R Marshall,Tiago R Magalhaes,Jennifer K Lowe,Jennifer L Howe,Anthony J Griswold,John Gilbert,Eftichia Duketis,Beth A Dombroski,Maretha V De Jonge,Michael Cuccaro,Emily L Crawford,Catarina T Correia,Judith Conroy,Inês C Conceição,Andreas G Chiocchetti,Jillian P Casey,Guiqing Cai,Christelle Cabrol,Nadia Bolshakova,Elena Bacchelli,Richard Anney,Steven Gallinger,Michelle Cotterchio,Graham Casey,Lonnie Zwaigenbaum,Kerstin Wittemeyer,Kirsty Wing,Simon Wallace,Herman van Engeland,Ana Tryfon,Susanne Thomson,Latha Soorya,Bernadette Rogé,Wendy Roberts,Fritz Poustka,Susana Mouga,Nancy Minshew,L Alison McInnes,Susan G McGrew,Catherine Lord,Marion Leboyer,Ann S Le Couteur,Alexander Kolevzon,Patricia Jiménez González,Suma Jacob,Richard Holt,Stephen Guter,Jonathan Green,Andrew Green,Christopher Gillberg,Bridget A Fernandez,Frederico Duque,Richard Delorme,Geraldine Dawson,Pauline Chaste,Cátia Café,Sean Brennan,Thomas Bourgeron,Patrick F Bolton,Sven Bölte,Raphael Bernier,Gillian Baird,Anthony J Bailey,Evdokia Anagnostou,Joana Almeida,Ellen M Wijsman,Veronica J Vieland,Astrid M Vicente,Gerard D Schellenberg,Margaret Pericak-Vance,Andrew D Paterson,Jeremy R Parr,Guiomar Oliveira,John I Nurnberger,Anthony P Monaco,Elena Maestrini,Sabine M Klauck,Hakon Hakonarson,Jonathan L Haines,Daniel H Geschwind,Christine M Freitag,Susan E Folstein,Sean Ennis,Hilary Coon,Agatino Battaglia,Peter Szatmari,James S Sutcliffe,Joachim Hallmayer,Michael Gill,Edwin H Cook,Joseph D Buxbaum,Bernie Devlin,Louise Gallagher,Catalina Betancur,Stephen W Scherer
DOI: https://doi.org/10.1016/j.ajhg.2014.03.018
2014-05-01
Abstract:Rare copy-number variation (CNV) is an important source of risk for autism spectrum disorders (ASDs). We analyzed 2,446 ASD-affected families and confirmed an excess of genic deletions and duplications in affected versus control groups (1.41-fold, p = 1.0 × 10(-5)) and an increase in affected subjects carrying exonic pathogenic CNVs overlapping known loci associated with dominant or X-linked ASD and intellectual disability (odds ratio = 12.62, p = 2.7 × 10(-15), ∼3% of ASD subjects). Pathogenic CNVs, often showing variable expressivity, included rare de novo and inherited events at 36 loci, implicating ASD-associated genes (CHD2, HDAC4, and GDI1) previously linked to other neurodevelopmental disorders, as well as other genes such as SETD5, MIR137, and HDAC9. Consistent with hypothesized gender-specific modulators, females with ASD were more likely to have highly penetrant CNVs (p = 0.017) and were also overrepresented among subjects with fragile X syndrome protein targets (p = 0.02). Genes affected by de novo CNVs and/or loss-of-function single-nucleotide variants converged on networks related to neuronal signaling and development, synapse function, and chromatin regulation.